9 Einträge gefunden

1. High levels of class III β-tubulin expression are associated with aggressive tumor features in breast cancer

   1. Lebok, Patrick
   2. Öztürk, Eray
   3. Heilenkötter, Uwe
   4. Jaenicke, Fritz
   5. Müller, Volkmar
   6. Paluchowski, Peter
   7. Geist, Stefan

   2016 - Forschungsinformationssystem des UKE
2. Cyclin D1 gene amplification is highly homogeneous in breast cancer

   1. Burandt, Eike
   2. Grünert , Martin
   3. Lebeau, Annette
   4. Choschzick, Matthias
   5. Quaas, Alexander
   6. Jänicke, Fritz
   7. Müller, Volkmar

   2016 - Forschungsinformationssystem des UKE
3. Loss of membranous VEGFR1 expression is associated with an adverse phenotype and shortened survival in breast cancer

   1. Lebok, Patrick
   2. Huber, Julia
   3. Burandt, Eike-Christian
   4. Lebeau, Annette
   5. Marx, Andreas Holger
   6. Terracciano, Luigi
   7. Heilenkötter, Uwe

   2016 - Forschungsinformationssystem des UKE
4. p16 overexpression and 9p21 deletion are linked to unfavorable tumor phenotype in breast cancer

   1. Lebok, Patrick
   2. Roming, Magdalena
   3. Kluth, Martina
   4. Koop, Christina
   5. Ozden, Cansu
   6. Taskin, B
   7. Hussein, K

   2016 - Forschungsinformationssystem des UKE
5. Loss of ALCAM expression is linked to adverse phenotype and poor prognosis in breast cancer: a TMA-based immunohistochemical study on 2,197 breast cancer patients

   1. Burandt, Eike
   2. Bari Noubar, Tanaz
   3. Lebeau, Annette
   4. Minner, Sarah
   5. Burdelski, Christoph
   6. Jänicke, Fritz
   7. Müller, Volkmar

   2014 - Forschungsinformationssystem des UKE
6. Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study.

   1. Kuehn, Thorsten
   2. Bauerfeind, Ingo
   3. Fehm, Tanja
   4. Fleige, Barbara
   5. Hausschild, Maik
   6. Helms, Gisela
   7. Lebeau, Annette

   2013 - Forschungsinformationssystem des UKE
7. German, Austrian and Swiss consensus conference on the diagnosis and local treatment of the axilla in breast cancer

   1. Hoffmann, Jürgen
   2. Souchon, Rainer
   3. Lebeau, Annette
   4. Öhlschlegel, Christian
   5. Gruber, Günther
   6. Rageth, Christoph
   7. Weber, Walter

   2013 - Forschungsinformationssystem des UKE
8. Rare oncogenic mutations of predictive markers for targeted therapy in triple-negative breast cancer.

   1. Grob, Tobias
   2. Heilenkötter, Uwe
   3. Geist, Stefan
   4. Paluchowski, Peter
   5. Wilke, Christian
   6. Jänicke, Fritz
   7. Quaas, Alexander

   2012 - Forschungsinformationssystem des UKE
9. Pathologic complete response after neoadjuvant chemotherapy plus trastuzumab predicts favorable survival in human epidermal growth factor receptor 2-overexpressing breast cancer: results from the TECHNO trial of the AGO and GBG study groups.

   1. Untch, Michael
   2. Fasching, Peter A
   3. Konecny, Gottfried E
   4. Hasmüller, Stephan
   5. Lebeau, Annette
   6. Kreienberg, Rolf
   7. Camara, Oumar

   2011 - Forschungsinformationssystem des UKE